Skip to main content
Figure 1 | BMC Neurology

Figure 1

From: Preliminary study: Treatment with intramuscular interferon beta-1a results in increased levels of IL-12Rβ2+ and decreased levels of IL23R+ CD4+ T - Lymphocytes in multiple sclerosis

Figure 1

Flow Cytometry of CD4 + IL23R + T Cells. Expression of IL-23R subunit on the cell surface of CD4 + T cells from MS patients treated with beta-interferon. (A) Results of one representative patient. (B) Percentage of IL-23R+ T cells from MS patients. Values are expressed as mean ± SEM. (C) Percentage of CD4+T cells expressing IL-23R in each MS patient treated with beta-interferon (n = 6).

Back to article page

BMC Neurology

ISSN: 1471-2377

Contact us